Endoscopic treatment of postoperative fistulas resistant to conservative management using biological fibrin glue

被引:121
作者
Rábago, LR [1 ]
Ventosa, N [1 ]
Castro, JL [1 ]
Marco, J [1 ]
Herrera, N [1 ]
Gea, F [1 ]
机构
[1] Hosp Severo Ochao Leganes, Secc Digest, Dept Gastroenterol, Madrid, Spain
关键词
D O I
10.1055/s-2002-33237
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background and Study Aims: Postoperative fistulae occur frequently in standard surgical practice, but there is no general agreement on how to treat them. We summarize here our experience with endoscopic treatment. Patients and Methods: Postoperative digestive fistulae resistant to conservative treatment, in 15 patients, are retrospectively reviewed. Our series included two internal fistulas: (one rectovesical, and one high-output pleuroesophagic), and 13 external fistulas (one low-output gastrocutaneous, two low-output esophagocutaneous, seven low-output enterocutaneous, and three high-output enterocutaneous). After failure of conservative treatment, the fistulas were endoscopically located and 2-4 ml of reconstituted fibrin glue, Tissucol 2.0 at 37degreesC, was injected through a catheter. Results: The mean age of the patients was 61.2 years (38-86), and 60% were men. Of the fistulas, 26.6% were of the high-out-put type. The mean healing time was 16 days (5-40), and a mean of 2.5 sessions per patient were required (1-5). Complete sealing of fistulas was achieved in 86.6% of cases; (87.5% of the low-output and internal fistulas, and 55% of the high-output fistulas): After follow-up ranging between 2 months and more than 3 years, only one of the sealed fistulas reopened. No complications were encountered. Overall mortality was 13.3% (two out of 15), but in only one patient was this related to clinical deterioration because of the persistence of the fistula. Conclusions: We think that conservative treatment should not be prolonged beyond 14 days and that endoscopic treatment should be performed at that stage. Endoscopic sealing treatment achieves a very high success rate, without complications and at a lower cost. It could probably reduce the hospital stay, and avoid some unnecessary surgical interventions. Appropriate multicenter randomized trials are needed to confirm these results.
引用
收藏
页码:632 / 638
页数:7
相关论文
共 39 条
[1]   AUTOLOGOUS FIBRIN GLUE IN THE TREATMENT OF RECTOVAGINAL AND COMPLEX FISTULAS [J].
ABEL, ME ;
CHIU, YSY ;
RUSSELL, TR ;
VOLPE, PA .
DISEASES OF THE COLON & RECTUM, 1993, 36 (05) :447-449
[2]  
Berry S M, 1994, Curr Probl Surg, V31, P469
[3]   Upper gastrointestinal tract fistulae: Endoscopic obliteration with fibrin sealant [J].
Cellier, C ;
Landi, B ;
Faye, A ;
Wind, P ;
Frileux, P ;
Cugnenc, PH ;
Barbier, JP .
GASTROINTESTINAL ENDOSCOPY, 1996, 44 (06) :731-733
[4]   Role of octreotide and somatostatin in the treatment of intestinal fistulae [J].
Dorta, G .
DIGESTION, 1999, 60 :53-56
[5]  
ELEFTHERIADIS E, 1990, ACTA CHIR SCAND, V156, P625
[6]   ENDOSCOPIC OCCLUSION OF A NEOPLASTIC ESOPHAGOMEDIASTINAL FISTULA BY A FAST-HARDENING AMINO-ACID SOLUTION [J].
ELL, C ;
RIEMANN, JF ;
DEMLING, L .
GASTROINTESTINAL ENDOSCOPY, 1986, 32 (04) :287-288
[7]  
FALCONI M, 2000, RES CLIN FORUMS, V22, P9
[8]  
Groitl H, 1987, Surg Endosc, V1, P93, DOI 10.1007/BF00312692
[9]  
HEDELIN H, 1982, SURG GYNECOL OBSTET, V154, P366
[10]  
Hernandez-Aranda J C, 1996, Nutr Hosp, V11, P226